We support VC/CVC teams, Private Equity, Hedge Funds, and other investors with decision-grade intelligence in BioPharma, HealthTech, and AI-enabled healthcare. From fast diligence to ongoing monitoring, we help you validate assumptions, surface risks early, and act with confidence.

From identifying emerging trends and hidden risks to supporting diligence and portfolio decisions, we deliver concise, actionable recommendations that create an edge.

Our work commonly includes:

  • Landscape + diligence (science, commercial, competitive dynamics)
  • Company/asset profile (TAM, segmentation, growth drivers, value proposition)
  • Opportunity/risk assessment (red flags, catalysts, scenarios, mitigations)
  • Custom research aligned to your thesis and timelines (deal-specific questions, thesis validation, monitoring)

Typical engagement modes:

  • Diligence Sprint (5–10 business days)
  • Monthly monitoring and brief updates
  • Decision workshops and AI-powered wargaming when stakes are high

Don’t forget to check out our Lucid Diligence Briefs, delivering 60-second theses, questions to ask, red flags and catalysts to watch, linked to trending news.

Want to move faster on your next decision? Contact: info@lqventures.com

Rare Diseases Weekly News – April 24th 2025

Cell and Gene Therapy Weekly News – April 24th 2025

Cardiovascular Weekly News – April 24th 2025

Immunology Weekly News – April 23rd 2025

Neuroscience Weekly News – April 23rd 2025

Endocrinology Weekly Update – 22nd April 2025

Obesity Weekly News – April 22nd 2025

Oncology Weekly News – April 21st 2025

Hematology Weekly News – April 21st 2025

Public Health Weekly News -18th April 2025

Respiratory Weekly News – 18th April 2025

Privacy Preference Center